Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study.

Sureshkumar P, Hodson EM, Willis NS, Barzi F, Craig JC.

Pediatr Nephrol. 2014 Jun;29(6):1039-46. doi: 10.1007/s00467-013-2736-9. Epub 2014 Feb 2.

PMID:
24488504
2.

Corticosteroid therapy for nephrotic syndrome in children.

Hodson EM, Knight JF, Willis NS, Craig JC.

Cochrane Database Syst Rev. 2004;(2):CD001533. Review. Update in: Cochrane Database Syst Rev. 2005;(1):CD001533.

PMID:
15106158
3.

Corticosteroid therapy for nephrotic syndrome in children.

Hodson EM, Knight JF, Willis NS, Craig JC.

Cochrane Database Syst Rev. 2003;(1):CD001533. Review. Update in: Cochrane Database Syst Rev. 2004;(2):CD001533.

PMID:
12535410
4.

Corticosteroid therapy for nephrotic syndrome in children.

Hodson EM, Knight JF, Willis NS, Craig JC.

Cochrane Database Syst Rev. 2001;(2):CD001533. Review. Update in: Cochrane Database Syst Rev. 2003;(1):CD001533.

PMID:
11405997
5.

Corticosteroid therapy for nephrotic syndrome in children.

Hodson EM, Knight JF, Willis NS, Craig JC.

Cochrane Database Syst Rev. 2000;(4):CD001533. Review. Update in: Cochrane Database Syst Rev. 2001;(2):CD001533.

PMID:
11034723
6.

Corticosteroid therapy for nephrotic syndrome in children.

Hahn D, Hodson EM, Willis NS, Craig JC.

Cochrane Database Syst Rev. 2015 Mar 18;(3):CD001533. doi: 10.1002/14651858.CD001533.pub5. Review.

PMID:
25785660
7.

Corticosteroid therapy for nephrotic syndrome in children.

Hodson EM, Knight JF, Willis NS, Craig JC.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001533. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD001533.

PMID:
15674881
8.

Corticosteroid therapy for nephrotic syndrome in children.

Hodson EM, Willis NS, Craig JC.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001533. Review. Update in: Cochrane Database Syst Rev. 2015;3:CD001533.

PMID:
17943754
9.

Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome.

Nakanishi K, Iijima K, Ishikura K, Hataya H, Nakazato H, Sasaki S, Honda M, Yoshikawa N; Japanese Study Group of Renal Disease in Children.

Clin J Am Soc Nephrol. 2013 May;8(5):756-62. doi: 10.2215/CJN.09010912. Epub 2013 Jan 31.

10.

Interventions for idiopathic steroid-resistant nephrotic syndrome in children.

Hodson EM, Wong SC, Willis NS, Craig JC.

Cochrane Database Syst Rev. 2016 Oct 11;10:CD003594. Review.

PMID:
27726125
11.

Non-corticosteroid treatment for nephrotic syndrome in children.

Durkan A, Hodson E, Willis N, Craig J.

Cochrane Database Syst Rev. 2001;(4):CD002290. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD002290.

PMID:
11687155
12.

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.

Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM.

Kidney Int. 2013 Nov;84(5):1025-33. doi: 10.1038/ki.2013.211. Epub 2013 Jun 5.

13.

Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.

Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.

Turk J Pediatr. 1999 Apr-Jun;41(2):225-30.

PMID:
10770662
14.

Parental Health Literacy and Outcomes of Childhood Nephrotic Syndrome.

Borges K, Sibbald C, Hussain-Shamsy N, Vasilevska-Ristovska J, Banh T, Patel V, Brooke J, Piekut M, Reddon M, Aitken-Menezes K, McNaughton A, Pearl RJ, Langlois V, Radhakrishnan S, Licht CPB, Piscione TD, Levin L, Noone D, Hebert D, Parekh RS.

Pediatrics. 2017 Mar;139(3). pii: e20161961. doi: 10.1542/peds.2016-1961. Epub 2017 Feb 17.

15.

Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.

Pravitsitthikul N, Willis NS, Hodson EM, Craig JC.

Cochrane Database Syst Rev. 2013 Oct 29;(10):CD002290. doi: 10.1002/14651858.CD002290.pub4. Review.

PMID:
24166716
16.

Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome.

Banh TH, Hussain-Shamsy N, Patel V, Vasilevska-Ristovska J, Borges K, Sibbald C, Lipszyc D, Brooke J, Geary D, Langlois V, Reddon M, Pearl R, Levin L, Piekut M, Licht CP, Radhakrishnan S, Aitken-Menezes K, Harvey E, Hebert D, Piscione TD, Parekh RS.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1760-1768. doi: 10.2215/CJN.00380116. Epub 2016 Jul 21.

17.

Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome.

Harambat J, Godron A, Ernould S, Rigothier C, Llanas B, Leroy S.

Pediatr Nephrol. 2013 Apr;28(4):631-8. doi: 10.1007/s00467-012-2365-8. Epub 2012 Nov 21.

PMID:
23179197
18.

Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.

Larkins N, Kim S, Craig J, Hodson E.

Arch Dis Child. 2016 Apr;101(4):404-8. doi: 10.1136/archdischild-2015-308924. Epub 2015 Aug 19. Review.

PMID:
26289063
19.

[Treatment outcome using prednisone in corticosteroid-responsive primary nephrotic syndrome in children].

Brumariu O, Cucer F, Munteanu M, Haliţchi C, Müller R, Russu R.

Rev Med Chir Soc Med Nat Iasi. 2005 Jul-Sep;109(3):492-6. Romanian.

PMID:
16607738
20.

Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome.

Takeda A, Takimoto H, Mizusawa Y, Simoda M.

Pediatr Nephrol. 2001 Nov;16(11):888-93.

PMID:
11685595

Supplemental Content

Support Center